Recent Updates
Recently added Catalysts
ALGS Positive Sentiment Score: 65/100

Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024

Tuesday, April 9, 2024 1 min read
Key Takeaway: Aligos Therapeutics, Inc. has announced its participation in the Piper Sandler Spring Biopharma Symposium 2024, scheduled for April 16-17 in Boston, Massachusetts. The company is focused on developing novel therapeutics for liver and viral diseases, particularly for conditions like metabolic dysfunction-associated steatohepatitis and hepatitis B. Their strategic approach leverages extensive drug development expertise, aiming to address significant unmet medical needs in these areas.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aligos Therapeutics is actively participating in a major industry event.
  • The company is focused on addressing unmet medical needs, which is a positive aspect for its mission.
  • Aligos has a strong strategy in place to develop therapeutics for significant health issues.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that management will participate in one-on-one meetings at the Piper Sandler Spring Biopharma Symposium 2024 being held in Boston, Massachusetts on April 16-17, 2024.
Please contact your Piper Sandler representative to schedule a one-on-one meeting.
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best-in-class therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) and viruses with high unmet medical need such as hepatitis B and coronaviruses.
Vice President, Investor Relations & Corporate Communications
LifeSci Communications
mfitzhugh@lifescicomms.com

Frequently Asked Questions

What is Aligos Therapeutics focused on?

Aligos Therapeutics develops novel therapeutics for liver and viral diseases.

When is the Piper Sandler Spring Biopharma Symposium?

The symposium is scheduled for April 16-17, 2024, in Boston, Massachusetts.

How can I schedule a meeting with Aligos management?

To schedule a meeting, contact your Piper Sandler representative.

When was Aligos Therapeutics founded?

Aligos Therapeutics was founded in 2018.

What diseases does Aligos aim to treat?

Aligos targets metabolic dysfunction-associated steatohepatitis and hepatitis B.

Tags: ALGS Viatris Investor Conferences Healthcare Aligos Therapeutics Piper Sandler biopharma liver diseases viral diseases
Last updated: Apr 9, 2024